104 related articles for article (PubMed ID: 1302556)
1. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer.
Sierra R; Muñoz N; Peña AS; Biemond I; van Duijn W; Lamers CB; Teuchmann S; Hernandez S; Correa P
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):449-54. PubMed ID: 1302556
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
3. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk.
Palli D; Decarli A; Cipriani F; Sitas F; Forman D; Amadori D; Avellini C; Giacosa A; Manca P; Russo A
Cancer Epidemiol Biomarkers Prev; 1993; 2(1):37-40. PubMed ID: 8420610
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
Sitas F; Smallwood R; Jewell D; Millard PR; Newell DG; Meuwissen SG; Moses S; Zwiers A; Forman D
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):119-23. PubMed ID: 8467246
[TBL] [Abstract][Full Text] [Related]
9. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection in gastric carcinoma.
Kato T; Saito Y; Niwa M; Inoue H; Motoyama N; Ogoshi K; Nashimoto A; Sasaki J; Sato T; Asaka M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S93-6. PubMed ID: 7735944
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
12. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
Con SA; Con-Wong R; Con-Chin GR; Con-Chin VG; Takeuchi H; Valerín AL; Echandi G; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767
[TBL] [Abstract][Full Text] [Related]
13. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.
Jonkers D; Houben P; Hameeteman W; Stobberingh E; de Bruine A; Arends JW; Biemond I; Lundqvist G; Stockbrügger R
Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):836-41. PubMed ID: 10669990
[TBL] [Abstract][Full Text] [Related]
14. Serum antibodies to Helicobacter pylori and the CagA antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates.
Groves FD; Perez-Perez G; Zhang L; You WC; Lipsitz SR; Gail MH; Fraumeni JF; Blaser MJ
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1091-4. PubMed ID: 12376512
[TBL] [Abstract][Full Text] [Related]
15. Serum gastrin, pepsinogens, parietal cell and Helicobacter pylori antibodies in patients with gastric polyps.
Bonilla Palacios JJ; Miyazaki Y; Kanayuma S; Yasunaga Y; Matsuzawa Y
Acta Gastroenterol Latinoam; 1994; 24(2):77-82. PubMed ID: 7817697
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection in two areas in Japan with different risks for gastric cancer.
Nobuta A; Asaka M; Sugiyama T; Kato M; Hige S; Takeda H; Kato T; Ogoshi K; Keida Y; Shinomura J
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():1-6. PubMed ID: 15298598
[TBL] [Abstract][Full Text] [Related]
17. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients.
Parente F; Imbesi V; Maconi G; Cucino C; Sangaletti O; Vago L; Bianchi Porro G
Am J Gastroenterol; 1998 Jul; 93(7):1073-9. PubMed ID: 9672333
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
19. Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections.
Nurgalieva ZZ; Opekun AR; Graham DY
Helicobacter; 2006 Apr; 11(2):69-74. PubMed ID: 16579835
[TBL] [Abstract][Full Text] [Related]
20. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
